Literature DB >> 19689731

Natural killer cell cytotoxicity: how do they pull the trigger?

Nicola J Topham1, Eric W Hewitt.   

Abstract

Natural killer (NK) cells target and kill aberrant cells, such as virally infected and tumorigenic cells. Killing is mediated by cytotoxic molecules which are stored within secretory lysosomes, a specialized exocytic organelle found in NK cells. Target cell recognition induces the formation of a lytic immunological synapse between the NK cell and its target. The polarized exocytosis of secretory lysosomes is then activated and these organelles release their cytotoxic contents at the lytic synapse, specifically killing the target cell. The essential role that secretory lysosome exocytosis plays in the cytotoxic function of NK cells is highlighted by immune disorders that are caused by the mutation of critical components of the exocytic machinery. This review will discuss recent studies on the molecular basis for NK cell secretory lysosome exocytosis and the immunological consequences of defects in the exocytic machinery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19689731      PMCID: PMC2747134          DOI: 10.1111/j.1365-2567.2009.03123.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  70 in total

Review 1.  Dynamin and its role in membrane fission.

Authors:  J E Hinshaw
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

2.  Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells.

Authors:  O Mandelboim; N Lieberman; M Lev; L Paul; T I Arnon; Y Bushkin; D M Davis; J L Strominger; J W Yewdell; A Porgador
Journal:  Nature       Date:  2001-02-22       Impact factor: 49.962

3.  Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions.

Authors:  Y M Vyas; K M Mehta; M Morgan; H Maniar; L Butros; S Jung; J K Burkhardt; B Dupont
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

4.  The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors.

Authors:  I Jordens; M Fernandez-Borja; M Marsman; S Dusseljee; L Janssen; J Calafat; H Janssen; R Wubbolts; J Neefjes
Journal:  Curr Biol       Date:  2001-10-30       Impact factor: 10.834

5.  Syntaxin 11 is an atypical SNARE abundant in the immune system.

Authors:  R Prekeris; J Klumperman; R H Scheller
Journal:  Eur J Cell Biol       Date:  2000-11       Impact factor: 4.492

6.  Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes.

Authors:  G Cantalupo; P Alifano; V Roberti; C B Bruni; C Bucci
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

7.  Phosphorylation of tyrosine 291 enhances the ability of WASp to stimulate actin polymerization and filopodium formation. Wiskott-Aldrich Syndrome protein.

Authors:  Giles O C Cory; Ritu Garg; Rainer Cramer; Anne J Ridley
Journal:  J Biol Chem       Date:  2002-09-15       Impact factor: 5.157

8.  Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses.

Authors:  Jordan S Orange; Narayanaswamy Ramesh; Eileen Remold-O'Donnell; Yoji Sasahara; Louise Koopman; Michael Byrne; Francisco A Bonilla; Fred S Rosen; Raif S Geha; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

9.  Rab27a is required for regulated secretion in cytotoxic T lymphocytes.

Authors:  J C Stinchcombe; D C Barral; E H Mules; S Booth; A N Hume; L M Machesky; M C Seabra; G M Griffiths
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

10.  Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice.

Authors:  E K Haddad; X Wu; J A Hammer; P A Henkart
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

View more
  86 in total

1.  Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers.

Authors:  Ian MacFawn; Hannah Wilson; Luke A Selth; Ian Leighton; Ilya Serebriiskii; R Christopher Bleackley; Osama Elzamzamy; Joshua Farris; Phillip M Pifer; Jennifer Richer; Steven M Frisch
Journal:  Mol Immunol       Date:  2018-11-30       Impact factor: 4.407

Review 2.  Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors:  C Klemann; L Wagner; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

3.  Two Cases of NK/T Cell Lymphoma Presenting as Chronic Rhinosinusitis.

Authors:  Rajat Thawani; Shishir Seth; Kuldeep Singh; Jayanta Patowary; Mano Bhadauria; Pratap Kishore Das
Journal:  Indian J Hematol Blood Transfus       Date:  2016-07-15       Impact factor: 0.900

Review 4.  Strategies to enhance NK cell function for the treatment of tumors and infections.

Authors:  Jacquelyn Freund-Brown; Leilani Chirino; Taku Kambayashi
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

5.  CRISPR/Cas9-Mediated GFP Reporter Knock-in in K562 and Raji Cell Lines for Tracking Immune Cell Killing Assay.

Authors:  Nontaphat Thongsin; Methichit Wattanapanitch
Journal:  Methods Mol Biol       Date:  2021

6.  IL-2 And IL-15 Induced NKG2D, CD158a and CD158b Expression on T, NKT- like and NK Cell Lymphocyte Subsets from Regional Lymph Nodes of Melanoma Patients.

Authors:  Ana Vuletić; Irena Jovanić; Vladimir Jurišić; Zorka Milovanović; Srđan Nikolić; Igor Spurnić; Gordana Konjević
Journal:  Pathol Oncol Res       Date:  2018-06-11       Impact factor: 3.201

7.  Expression of CD94 by ex vivo-differentiated NK cells correlates with the in vitro and in vivo acquisition of cytotoxic features.

Authors:  Meriem Hasmim; Nadine Khalife; Yanyan Zhang; Manale Doldur; Geralidne Visentin; Stéphane Terry; Julien Giron-Michel; Ruoping Tang; François Delhommeau; Nicolas Dulphy; Jean-Henri Bourhis; Fawzia Louache; Salem Chouaib
Journal:  Oncoimmunology       Date:  2017-07-18       Impact factor: 8.110

Review 8.  DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.

Authors:  Jixin Zhong; Andrei Maiseyeu; Stephen N Davis; Sanjay Rajagopalan
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

Review 9.  Paving the way towards universal treatment with allogenic T cells.

Authors:  Michelle H Townsend; Kelsey Bennion; Richard A Robison; Kim L O'Neill
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

10.  Correlation of tumor-associated macrophages and NK cells with bladder cancer size and T stage in patients with solitary low-grade urothelial carcinoma.

Authors:  Kristian Krpina; Emina Babarović; Josip Španjol; Gordana Đorđević; Tobias Maurer; Nives Jonjić
Journal:  Wien Klin Wochenschr       Date:  2015-12-11       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.